Emmett Cunningham
Directeur/Bestuurslid bij GALERA THERAPEUTICS, INC.
Vermogen: - $ op 31-05-2024
Profiel
Emmett T.
Cunningham is the founder of Ophthalmology Innovation Summit (founded in 2009) and Placid0, Inc. (founded in 2020).
Dr. Cunningham is also the founder of Pr3vent, Inc..
Dr. Cunningham's current job(s) include Director at SARcode Bioscience, Inc., Independent Director at Galera Therapeutics, Inc., Director-Uveitis Service at California Pacific Medical Center, Senior Managing Director at Blackstone, Inc., Director at SFJ Pharmaceuticals, Inc., Director at Lumos Pharma Sub, Inc., Director at Viewpoint Therapeutics, Inc., Director at Silk Technologies Ltd., Adjunct Professor at Stanford University School of Medicine, Research Associate at UCSF School of Medicine, Research Associate at Francis I Proctor Foundation, and Senior Partner at Healthquest Capital Management Co LLC (starting in 2023).
Dr. Cunningham's former job(s) include Director at NewLink Genetics Corp., Independent Director at Restoration Robotics, Inc. (from 2011 to 2018), Director at Annexon, Inc. (from 2014 to 2021), Director at Graybug Vision, Inc. (from 2016 to 2020), Director at The University of California, San Francisco (from 1995 to 2001), Managing Director & Partner at Clarus Ventures LLC (from 2006 to 2018), Senior Managing Director at Blackstone Life Sciences Advisors LLC, Independent Director at Lumos Pharma, Inc. (from 2016 to 2021), Principal at Pfizer Inc., Senior Vice President-Medical Strategy at Oldtech, Inc. (from 2001 to 2005), and Professor at New York University (from 2002 to 2005).
Dr. Cunningham's education history includes an undergraduate degree from Drexel University, graduate and doctorate degrees from The Johns Hopkins University, and a doctorate degree from the University of California San Diego.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-06-2023 | 0 ( -.--% ) | - $ | 31-05-2024 |
Actieve functies van Emmett Cunningham
| Bedrijven | Functie | Begin |
|---|---|---|
| GALERA THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-09-2018 |
| BLACKSTONE INC. | Private Equity Investor | - |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Directeur/Bestuurslid | - |
Silk Technologies Ltd.
 Silk Technologies Ltd. Pharmaceuticals: MajorHealth Technology Silk Technologies Ltd. develops silk-derived protein (SDP) products for ophthalmic applications. Its patented SDP material is currently being developed as a compound for the treatment of patients with dry eye disease. The company was founded by Brian D. Lawrence and is headquartered in Plymouth, MN. | Directeur/Bestuurslid | - |
| Stanford University School of Medicine | Corporate Officer/Principal | 01-07-2008 |
| UCSF School of Medicine | Corporate Officer/Principal | - |
| Francis I Proctor Foundation | Corporate Officer/Principal | - |
California Pacific Medical Center
 California Pacific Medical Center Miscellaneous Commercial ServicesCommercial Services California Pacific Medical Center operates medical centers. It offers acute and specialty care services including obstetrics, gynecology, cardiovascular, pediatrics, neurosciences, orthopedics, and organ transplantation. The company is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
SFJ Pharmaceuticals, Inc.
 SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology SFJ Pharmaceuticals, Inc. develops pharmaceuticals drugs. It offers drugs for cancer, kidney, thyroid, leukemia, and lung cancer. The company was founded by Roberto DeBenedetto in January 2009 and is headquartered in Pleasanton, CA. | Directeur/Bestuurslid | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
Eerdere bekende functies van Emmett Cunningham
| Bedrijven | Functie | Einde |
|---|---|---|
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Emmett Cunningham
| Drexel University | Undergraduate Degree |
| The Johns Hopkins University | Doctorate Degree |
| University of California San Diego | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| PFIZER, INC. | Health Technology |
| ANNEXON, INC. | Health Technology |
| GALERA THERAPEUTICS, INC. | Health Technology |
| BLACKSTONE INC. | Finance |
| LUMOS PHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 17 |
|---|---|
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Health Technology |
SARcode Bioscience, Inc.
 SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA. | Health Technology |
Restoration Robotics, Inc.
 Restoration Robotics, Inc. Medical SpecialtiesHealth Technology Restoration Robotics, Inc. manufactures and develops medical devices for hair transplantation services. It provides artas system, a computer-assisted, physician-controlled system to harvest follicular units directly from the scalp. It operates in the United States, Europe and Middle East, Asia pacific, and Rest of the World. The company was founded by Mohan Bodduluri, Don Caddes, Phillip L. Gildenberg and Fredrick H. Moll on November 22, 2002 and is headquartered in San Jose, CA. | Health Technology |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Graybug Vision, Inc. develops ophthalmic drugs. It focus on developing drug delivery therapies for the treatment of eye diseases such as age-related macular degeneration and glaucoma. The company was founded by Justin S. Hanes, Peter John McDonnell, Christy Wyskiel and Peter A. Campochiaro in May 2011 and is headquartered in Redwood City, CA. | Health Technology |
California Pacific Medical Center
California Pacific Medical Center Miscellaneous Commercial ServicesCommercial Services California Pacific Medical Center operates medical centers. It offers acute and specialty care services including obstetrics, gynecology, cardiovascular, pediatrics, neurosciences, orthopedics, and organ transplantation. The company is headquartered in San Francisco, CA. | Commercial Services |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Finance |
SFJ Pharmaceuticals, Inc.
SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology SFJ Pharmaceuticals, Inc. develops pharmaceuticals drugs. It offers drugs for cancer, kidney, thyroid, leukemia, and lung cancer. The company was founded by Roberto DeBenedetto in January 2009 and is headquartered in Pleasanton, CA. | Health Technology |
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Health Services |
Healthquest Capital Management Co LLC
 Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital ) is a private equity firm founded in 2013 by Garheng Kong and Randy L. Scott. The firm is headquartered in Redwood City, California. | Finance |
Viewpoint Therapeutics, Inc.
 Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Viewpoint Therapeutics, Inc. operates as a biotechnology company. It prevents and treats cataracts and presbyopia, and protein misfolding. The company was founded by Leah Makley in July of 2014 and is headquartered in San Francisco, CA. | Health Technology |
Silk Technologies Ltd.
Silk Technologies Ltd. Pharmaceuticals: MajorHealth Technology Silk Technologies Ltd. develops silk-derived protein (SDP) products for ophthalmic applications. Its patented SDP material is currently being developed as a compound for the treatment of patients with dry eye disease. The company was founded by Brian D. Lawrence and is headquartered in Plymouth, MN. | Health Technology |
Ophthalmology Innovation Summit
 Ophthalmology Innovation Summit Financial ConglomeratesFinance Ophthalmology Innovation Summit provides investment services. The private company is based in Jericho. The American company was founded by Emmett T. Cunningham, Gilbert H. Kliman. | Finance |
Pr3vent, Inc
 Pr3vent, Inc Medical/Nursing ServicesHealth Services Pr3vent, Inc provides healthcare technology services. The company was founded by Jochen Kumm and Darius M. Moshfegh and is headquartered in Palo Alto, CA. | Health Services |
Blackstone Life Sciences Advisors LLC
 Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences Advisors LLC (Blackstone Life Sciences) is a private equity subsidiary of Blackstone, Inc. founded in 2017. The firm is headquartered in New York. | Finance |
| Francis I Proctor Foundation | |
Placid0, Inc.
 Placid0, Inc. Packaged SoftwareTechnology Services Part of Ainsly Ltd., Placid0, Inc. develops a mobile platform for assessing ocular conditions. The company is based in Pasadena, CA. The company was founded in 2020 by Andrew Moshfeghi, Zach Bodnar, Darius M. Moshfeghi, Jochen Kumm, Emmett T. Cunningham. Placid0 was acquired by Ainsly Ltd. on February 10, 2022. | Technology Services |
